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Abstract
Background
We have previously performed a Genome Wide Association and linkage study that indicated
a new disease triggering mechanism involving amino acid metabolism and nutrient sensing
signaling pathways.
Objective
The aim of this study was to investigate if plasma amino acid levels differed among children
with celiac disease compared with disease controls.
Materials and methods
Fasting plasma samples from 141 children with celiac disease and 129 non-celiac disease
controls, were analyzed for amino acid levels by liquid chromatography-tandem mass spec-
trometry (LC/MS). A general linear model using age and experimental effects as covariates
was used to compare amino acid levels between children with a diagnosis of celiac disease
and controls.
Results
Seven out of twenty-three analyzed amino acids were elevated in children with celiac dis-
ease compared with controls (tryptophan, taurine, glutamic acid, proline, ornithine, alanine
and methionine). The significance of the individual amino acids do not survive multiple cor-
rection, however, multivariate analyses of the amino acid profile showed significantly altered
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amino acid levels in children with celiac disease overall and after correction for age, sex and
experimental effects (p = 8.4 × 10−8).
Conclusion
These findings support the idea that amino acids could influence systemic inflammation and
play a possible role in disease pathogenesis.
Introduction
Celiac disease is manifested as an intolerance to gluten in genetically at risk individuals, lead-
ing to an autoimmune response to tissue transglutaminase (tTG) [1]. By excluding gluten
from the diet the damaged intestinal mucosa is restored in most patients and tTG autoanti-
body (tTGA) levels normalized [2]. Although gluten and certain HLA-genotypes are necessary
for celiac disease to develop, the mechanisms by which autoimmunity can be switched on and
off by an external food antigen still remains unresolved.
We previously performed a Genome Wide Associations Study (GWAS) in patients with
celiac disease, which pointed towards genes involved in nutrient and amino acid signaling [3].
The differential RNA expression of some of these genes (PRR5L, GLS, APPL2 and INSR) in
celiac disease as compared to disease controls, further indicated possibly disturbed mecha-
nisms in nutrient sensing pathways [3]. Whether this is an effect of an underlying disturbed
metabolism caused by a damaged intestinal mucosa or vice versa, still remains to be elucidated.
In patients affected by other chronic diseases such as type 2 diabetes [4–7], Alzheimer [8],
autism [9] and in psoriasis [10], the amino acid profile have been shown to differ from healthy
individuals. Amino acid concentrations also differ by age; adolescents with type 2 diabetes
tend to have lower levels as compared with healthy individuals, [11] while levels are increased
in adults with type 2 diabetes [12], indicating that studies need to be performed on pediatric
and adult patients separately.
Amino acids can be used as energy as well as influence cell metabolism and immunity. A
well-studied signaling pathway connecting amino acid signaling and immunity is the Target of
Rapamycin (TOR) pathway [13]. Interestingly, several of the genes identified by our GWAS
belong to this signaling pathway. We also found a possible connection between extra cellular
matrix and celiac disease. Extracellular matrix is a storage reservoir for certain amino acids
such as proline and hydroxyproline and these amino acids are used as energy during starving
conditions. However, when not starving, the release of these amino acids could be a so called
endogenous danger signal [14] for the immune system. We therefore hypothesized that certain
amino acids, liberated upon gluten metabolism, are involved in signaling to the immune sys-
tem, ultimately leading to chronic inflammation [3]. In this study, we aimed to investigate if
levels of these amino acids are different in plasma from children with celiac disease compared
with controls.
Materials and methods
Subjects
Peripheral blood samples were consecutively collected from 141 children with untreated celiac
disease and 129 disease controls (Table 1). The aim was to include all children who underwent
upper endoscopy at the pediatric gastroenterology units in Malmo¨, Gothenburg and Stock-
holm, Sweden between 2010 and 2012[15]. Children were fasting at least 6 hours prior to
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endoscopy procedure performed in general sedation with propofol. Children being positive
for tTGA and showing characteristic villous atrophy of the distal part of duodenum (Marsh
2) were defined as having celiac disease whereas tTGA positive children having a Marsh <2
were defined as having potential celiac disease. Children being tTGA negative with a normal
biopsy excluding celiac disease were included as disease controls.
All participants were informed about the study and a parental written consent was obtained
for each child. The regional ethical review board (EPN) in Gothenburg Sweden approved the
study.
Sample preparation
Eight different batches were prepared separately. 900 μL of extraction buffer (90/10 v/v metha-
nol:water) including internal standards were added to 100 μL of sample material. The sample
was shaken at 30 Hz for 2 minutes in a mixer mill and proteins were precipitated at +4˚C on
ice. The sample was centrifuged at +4˚C, 14 000 rpm, for 10 minutes. 100 μL of supernatant
were transferred to a micro vial and solvents were evaporated. Samples were derivatized with
AccQ-Tag™ (Waters, Milford, MA, USA). The derivatization was performed according to the
manufacturer’s protocol; the dried extracts were re-suspended in 20 μL of 20 mM HCl, and
60 μL of AccQ•Tag Ultra borate buffer were added to each sample for pH adjustment. Finally
20 μL of freshly prepared AccQ•Tag derivatization solution were added and the sample was
immediately vortexed for 10 seconds. After mixing, the samples were allowed to stand for 30
minutes at room temperature followed by 10 minutes at 55˚C. A 14-point calibration set cov-
ering the range from 5 fmol to 5 pmol on column was prepared and analysed in triplicates.
Norvaline was used as internal standard in a concentration of 0.5 pmol/μL in both samples
and in the calibration set.
Analysis
Liquid chromatography-tandem mass spectrometry (LC/MS) measurements were performed
on a 1290 Infinity system from Agilent Technologies (Waldbronn, Germany), with an Agilent
6460 Triple quadrupole mass spectrometer for MRM-detection. The analysis was performed
as follows.
1 μL aliquots of the derivatized samples sample were injected onto a 2.1 x 100 mm, 1.7 μm
UHPLC Kinetex C18-column (Phenomenex Torrance, CA, USA) held at 50˚C in a column
oven. The gradient elution buffers were A (H2O, 0.1% formic acid) and B (acetonitrile, 0.1%
formic acid), and the flow-rate was 500 μl min-1; mass spectrometry grade formic acid was
purchased from Sigma-Aldrich (St Louis, MO, USA) and HPLC grade acetonitrile from Fisher
Scientific (Fair Lawn, NJ, USA). The initial condition (0.1% B) was held up to 0.54 minutes.
From 0.54 to 5.5 minutes the proportion of solvent B was linearly increased from 0.1% to
9.1%. From 5.5 minutes, B was increased linearly to reach 21.2% at 7.7 minutes. From 7.7 min
to 8.5 min the percentage of B was further increased to 59.6% and held there for 0.5 minutes.
To elute the more non-polar compounds, the proportion of solvent B was then rapidly
Table 1. Clinical characteristics according to diagnostic status: Celiac disease and disease controls. Age is pre-
sented as mean (SD, min-max). The p-values were calculated using ANOVA and Chi-square test.
Celiac disease
n = 141
Disease control n = 129 P-value
Age, years 6.6 (3.8, 1,6–17,8) 12 (4.4, 1.4–18) 6.10 x 10−12
Females, n (%) Male, n (%) 98 (69.5%)43 (30.5%) 74 (57.4%)55 (42.6%) 0.043
https://doi.org/10.1371/journal.pone.0193764.t001
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increased to 80% at 9.5 min and kept there for 0.5 minutes. From 10 to 10.5 minutes the col-
umn was returned to its initial conditions (0.1% B), and the column was equilibrated for 4.5
minutes before injection of the subsequent sample.
The separated amino acids were detected with an Agilent 6460 triple quadrupole (QqQ)
mass spectrometer equipped with a jet stream electrospray source operating in positive ion
mode. The jet-stream gas temperature was 325˚C with a gas flow rate of 10 L min-1, sheath gas
temperature of 325˚C, and sheath gas flow of 12 L min-1. The nebulizer pressure was set to 20
psi and the capillary voltage was set at 4 kV. The QqQ was run in Dynamic MRM Mode with
0.5 minute retention time windows and 500 ms cycle scans. MRM transitions for the deriva-
tized amino acids were optimized using MassHunter MS Optimizer software (Agilent Tech-
nologies Inc., Santa Clara, CA, USA). The optimized fragmentation voltages varied from 81–
119 V and the collision energies from 14–35 V; nitrogen was used as collision gas.
Quantification of the compounds was performed with MassHunter™ Quantitative Analysis
QQQ (Agilent Technologies Inc., Santa Clara, CA, USA). Calibrators were used to construct a
standard curve by plotting the ratio of analyte area/internal standard area against the corre-
sponding concentrations of the calibrators. The slope and intercept of the standard curve were
used to calculate the concentration of the analyte in the samples using the equation y = ax + b,
where y is area ratio, a is slope, x is concentration and b is intercept.
Statistical analysis
A general linear model, using age and experimental effects such as run batch, as covariates
were used to compare amino acid levels between children with a diagnosis of celiac disease
with control children. Partial correlation coefficients controlling for age and experimental
effects were calculated for all pairs of amino acids. We used Hotelling’s Trace test, corrected
for age and experimental effects (such as batch effects and sample handling temperature), to
analyze the overall difference in amino acid levels.
Results
In total, seven out of the 23 amino acids tested showed individually nominally significantly
higher levels in children with celiac disease compared with controls after correction for age
and experimental effects. The most significant was tryptophane (p = 0.004) (Table 2). Further-
more, taurine, glutamic acid, proline, ornithine, alanine and Methionine were also nominally
significant for celiac disease (p<0.05). (Table 2). When using permutation analyses for correc-
tion of multiple testing, none of the single amino acids remained significant. However, overall
levels of amino acids in plasma were significantly associated with celiac disease
(p = 8.4 × 10−8). No significance was detected for the so called Fischer’s ratio (branched-chain
amino acids (leucine, valine, isoleucine) to aromatic amino acids (phenylalanine, tyrosine).
Higher levels of amino acids were also strongly associated with age, with higher levels
among older children in 18 of the 23 analyzed amino acids. Leucine (p = 5.9 × 10−13), lysine
(p = 1.82 × 10−12), phenylalanine (p = 1.62 × 10−11), isoleucine (p = 9.01 × 10−11), proline
(p = 2.63 × 10−10) and citrulline (p = 7.21 × 10−10) being the six most significantly affected by
age (Table 2).
To investigate the interrelationships between different amino acids we calculated the corre-
lation between each pair of amino acids. Partial correlation coefficients were significant for
almost all amino acid pairs (S2 Table). The most significant correlation was between citrulline
and proline (correlation coefficient 0.91, p-value < 0.0001).
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Discussion
This study found that children with untreated celiac disease had increased levels of seven
amino acids (tryptophan, taurine, glutamic acid, ornithine, proline, alanine and methionine)
compared with disease controls. Another important finding was that almost all amino acids
correlated with each other and that the overall level of amino acids was different between cases
and controls (p = 8.4 × 10−8). This could make it difficult to single out any one amino acid
Table 2. Multivariate analysis of the difference between children with celiac disease (cases) and controls. Amino acid levels are analyzed using a general linear model
with age, sex and experimental effects as covariates. Nominal p-values are presented for diagnosis of celiac disease vs controls, for age of sampling and for sex. Mean levels
are reported as concentrations in plasma (pmol/μl).
Amino acid CD vs. control Age Controls CD
p-value p-value Mean pmol/μl Mean pmol/μl
Tryptophane 0.004 0.01 43.8 45.9
Taurine 0.005 1.13E-03 86.9 99.6
Glutamic Acid 0.015 0.45 106.3 123.7
Proline 0.017 2.63E-10 160.9 156.2
Ornithine 0.017 1.28E-05 80.8 83.3
Alanine 0.045 7.60E-07 299.9 300.3
Methionine 0.048 4.87E-09 16.4 17.0
Phenylalanine 0.075 1.62E-11 48.3 47.7
Glutamine 0.136 0.10 515.4 486.8
Aspartic Acid 0.142 0.36 9.1 12.4
Tyrosine 0.147 8.21E-04 64.0 63.8
Leucine 0.156 5.90E-13 132.7 125.0
Histidine 0.158 5.82E-04 106.7 110.1
Cysteine 0.171 1.76E-07 13.7 14.7
Serine 0.275 0.91 139.9 146.4
Valine 0.485 3.97E-06 194.5 189.6
Lysine 0.562 1.82E-12 125.7 122.7
Glycine 0.57 0.62 216.2 223.6
Threonine 0.709 9.39E-07 93.9 93.4
Citrulline 0.799 7.21E-10 149.6 129.3
Arginine 0.847 3.00E-05 36.8 33.1
Asparagine 0.864 5.46E-04 54.1 54.8
Isoleucine 0.928 9.01E-11 60.3 54.5
CD = Celiac disease. Nominally significant p-values in the CD vs Control group are presented in bold.
https://doi.org/10.1371/journal.pone.0193764.t002
Fig 1. The interrelationship between associated amino acids, proline, ornithine and glutamic acid.
https://doi.org/10.1371/journal.pone.0193764.g001
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which would be important for disease pathogenesis. However, even though the single amino
acids are only nominally significant, the fact that proline and glutamic acid was nominally sig-
nificantly higher in children with celiac disease supports our previous hypothesis that these
amino acids, which also are abundant in wheat gluten, could be causal in triggering the disease
[3].
Interestingly, high proline and glutamic acid levels have also been shown to associate with
psoriasis [10], another autoimmune disease affecting the skin and high glutamic acid values
are associated with the subsequent appearance of the type 1 diabetes associated autoantibodies
in young children[16]. Out of the seven amino acids that showed changes in levels, glutamic
acid, ornithine and proline are tightly interconnected with each other (Fig 1) Glutamic acid
and proline together account for one half or more of the peptide-bound amino acids in wheat
gluten[17]. It is possible that children with celiac disease, either eat a larger amount of gluten
containing foods, or that they have a slightly impaired metabolism regarding these amino
acids and therefore have an elevated level.
Almost all amino acid levels correlated significantly with age, which is in line with a pre-
vious study[18]. Younger children had lower levels and older children had higher levels of
amino acids. In this study, children with celiac had higher levels at all ages compared with
controls of the same age. Lower levels of amino acids in younger children could perhaps
indicate higher sensitivity to a disturbance of the amino acid balance. In contrast to chil-
dren, amino acid levels in a study of adult patients demonstrated lower levels of multiple
amino acids in untreated celiac disease compared with healthy adults[19]. This could possi-
bly reflect differences between pediatric and adult celiac disease that could be related to lon-
ger duration of inflammation in adult patients resulting perhaps in a relative deficiency in
amino acids.
The strength of this study was the large number of patients recruited and the relatively uni-
form handling of the samples from patients consecutively collected at a limited number of col-
lection sites. The weaknesses of this study were that the controls were older than the cases and
that controls were also children with potential gastrological diseases. The cases and controls
were significantly different regarding age. The reason for this was that all children who made
an upper endoscopy were included in the study and children with celiac disease usually have a
lower age at diagnosis.
However, when adjusting for age as well as experimental effects and sample handling proce-
dures, the findings still remained different between children with active celiac disease com-
pared with disease controls.
In conclusion, children with active celiac disease have increased levels of certain amino
acids in peripheral blood. Overall these findings supports the possibility that metabolism of
amino acids could influence systemic inflammation. However, it is still unclear whether these
findings are consequences of the inflammation found in patients with celiac disease or perhaps
the results of a genetic predisposition in combination with environmental risk factors. Future
studies on samples collected prior to diagnosis are therefore warranted in order to help disen-
tangle the role of amino acid levels in celiac disease pathogenesis.
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